A detailed history of Burney CO transactions in Alkermes Plc. stock. As of the latest transaction made, Burney CO holds 19,332 shares of ALKS stock, worth $574,353. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,332
Previous 21,349 9.45%
Holding current value
$574,353
Previous $514,000 5.25%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$23.01 - $28.55 $46,411 - $57,585
-2,017 Reduced 9.45%
19,332 $541,000
Q2 2024

Jul 29, 2024

SELL
$23.21 - $27.24 $35,464 - $41,622
-1,528 Reduced 6.68%
21,349 $514,000
Q1 2024

May 22, 2024

SELL
$26.4 - $32.56 $4.06 Million - $5 Million
-153,634 Reduced 87.04%
22,877 $619,000
Q4 2023

Feb 12, 2024

SELL
$23.37 - $28.68 $20,261 - $24,865
-867 Reduced 0.49%
176,511 $4.9 Million
Q3 2023

Nov 08, 2023

BUY
$27.17 - $31.97 $3.5 Million - $4.12 Million
128,788 Added 265.05%
177,378 $4.97 Million
Q2 2023

Aug 09, 2023

BUY
$28.34 - $33.63 $1.38 Million - $1.63 Million
48,590 New
48,590 $1.52 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Burney CO Portfolio

Follow Burney CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.